Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for OneMedNet (ONMD) over the last 4 years, with Q3 2025 value amounting to $54000.0.

  • OneMedNet's Gains from Investment Securities rose 20588.24% to $54000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 16496.34%. This contributed to the annual value of $120000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, OneMedNet's Gains from Investment Securities stood at $54000.0, which was up 20588.24% from $314000.0 recorded in Q2 2025.
  • OneMedNet's Gains from Investment Securities' 5-year high stood at $913.9 million during Q4 2022, with a 5-year trough of -$2.8 million in Q1 2022.
  • Over the past 4 years, OneMedNet's median Gains from Investment Securities value was $54000.0 (recorded in 2025), while the average stood at $82.9 million.
  • In the last 5 years, OneMedNet's Gains from Investment Securities crashed by 10591.47% in 2024 and then soared by 768571.43% in 2025.
  • OneMedNet's Gains from Investment Securities (Quarter) stood at $913.9 million in 2022, then plummeted by 99.91% to $862260.0 in 2023, then tumbled by 80.17% to $171000.0 in 2024, then plummeted by 68.42% to $54000.0 in 2025.
  • Its last three reported values are $54000.0 in Q3 2025, $314000.0 for Q2 2025, and $531000.0 during Q1 2025.